Summit Therapeutics Inc. Adjustments For Increase Decrease In Trade And Other Payables
Summit Therapeutics Inc. (SMMT) reported Adjustments For Increase Decrease In Trade And Other Payables of GBP 1.58 million for the 3-month period ending 2020-03-31, per its 6-K filed 2020-06-02.
Discontinued › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables · last filed 2020-06-02
- Summit Therapeutics Inc. adjustments for increase decrease in trade and other payables for the quarter ending 2020-03-31 was 1.58M GBP.
- Summit Therapeutics Inc. adjustments for increase decrease in trade and other payables for the quarter ending 2019-10-31 was 686.00K GBP.
- Summit Therapeutics Inc. adjustments for increase decrease in trade and other payables for the quarter ending 2019-07-31 was -461.00K GBP.
- Summit Therapeutics Inc. adjustments for increase decrease in trade and other payables for the quarter ending 2019-04-30 was -2.02M GBP, a 167.21% decline year-over-year.
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 3 month | Adjustments For Increase Decrease In Trade And Other Payables 3 month as first filed | Adjustments For Increase Decrease In Trade And Other Payables 6 month | Adjustments For Increase Decrease In Trade And Other Payables 6 month as first filed | Adjustments For Increase Decrease In Trade And Other Payables 9 month | Adjustments For Increase Decrease In Trade And Other Payables 9 month as first filed | Adjustments For Increase Decrease In Trade And Other Payables 11 month | Adjustments For Increase Decrease In Trade And Other Payables 12 month | Adjustments For Increase Decrease In Trade And Other Payables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | 1.58M GBP 6-K · filed 2020-06-02 | ||||||||
| 2019-12-31 | -1.00M GBP 20-F · filed 2020-04-30 | ||||||||
| 2019-10-31 | 686.00K GBP derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | 225.00K GBP derived: sum of 2 quarters · filed 2019-12-17 | -1.80M GBP 6-K · filed 2019-12-17 | ||||||
| 2019-07-31 | -461.00K GBP derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | -2.48M GBP 6-K · filed 2019-10-11 | |||||||
| 2019-04-30 | -2.02M GBP 6-K · filed 2019-06-12 | ||||||||
| 2019-03-31 | -2.27M GBP 6-K · filed 2020-06-02 | ||||||||
| 2019-01-31 | 3.79M GBP derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | 2.45M GBP derived: sum of 2 quarters · filed 2020-04-30 | -2.94M GBP derived: sum of 3 quarters · filed 2020-04-30 | 68.00K GBP 20-F · filed 2020-04-30 | 93.00K GBP 20-F · filed 2019-03-29 | ||||
| 2018-10-31 | -1.34M GBP derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | -6.73M GBP derived: sum of 2 quarters · filed 2019-12-17 | -3.72M GBP 6-K · filed 2019-12-17 | -3.70M GBP 6-K · filed 2018-12-11 | -369.00K GBP derived: sum of 4 quarters · filed 2020-04-30 | ||||
| 2018-07-31 | -5.38M GBP derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | -2.38M GBP 6-K · filed 2019-10-11 | -2.36M GBP 6-K · filed 2018-09-20 | 972.00K GBP derived: sum of 3 quarters · filed 2020-04-30 | 1.37M GBP derived: sum of 4 quarters · filed 2020-04-30 | ||||
| 2018-04-30 | 3.01M GBP 6-K · filed 2019-06-12 | 3.02M GBP 6-K · filed 2018-06-05 | 6.36M GBP derived: sum of 2 quarters · filed 2020-04-30 | 6.75M GBP derived: sum of 3 quarters · filed 2020-04-30 | 7.07M GBP derived: sum of 4 quarters · filed 2020-04-30 | ||||
| 2018-01-31 | 3.35M GBP derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | 3.75M GBP derived: sum of 2 quarters · filed 2020-04-30 | 4.07M GBP derived: sum of 3 quarters · filed 2020-04-30 | 3.27M GBP 20-F · filed 2020-04-30 | 3.38M GBP 20-F · filed 2018-04-13 | ||||
| 2017-10-31 | 396.00K GBP derived: 6-K 9 month − 6-K 6 month · filed 2018-12-11 | 716.00K GBP derived: sum of 2 quarters · filed 2018-12-11 | -82.00K GBP 6-K · filed 2018-12-11 | ||||||
| 2017-07-31 | 320.00K GBP derived: 6-K 6 month − 6-K 3 month · filed 2018-09-20 | -478.00K GBP 6-K · filed 2018-09-20 | |||||||
| 2017-04-30 | -798.00K GBP 6-K · filed 2018-06-05 | ||||||||
| 2017-01-31 | 813.00K GBP 20-F · filed 2019-03-29 | ||||||||
| 2016-01-31 | -366.00K GBP 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |